Click for best price
AntiCathepsin B Market Size, Share 2024
Cathepsin B belongs to a family of lysosomal cysteine proteases. It plays an important role in intracellular proteolysis. In humans, Cathepsin B is encoded by the CTSB gene. Anti-Cathepsin B antibody is used to treat cancers, traumatic brain injuries, Ebola infection, and fertility issues.
This report aims to provide a comprehensive presentation of the global market for Anti-Cathepsin B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Cathepsin B. This report contains market size and forecasts of Anti-Cathepsin B in global, including the following market information:
Global Anti-Cathepsin B Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
The global Anti-Cathepsin B market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Primary Antibodies Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Anti-Cathepsin B include Merck KGaA, Bio-Techne, BioVision Inc., Santa Cruz Biotechnology, Inc., MedChemExpress, BioCat GmbH, ApexBio Technology, Cayman Chemical, Selleck Chemicals and BOC Sciences, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-Cathepsin B companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Cathepsin B Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Anti-Cathepsin B Market Segment Percentages, by Type, 2023 (%)
Primary Antibodies
Proteins and Peptides
Lysates
Global Anti-Cathepsin B Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Anti-Cathepsin B Market Segment Percentages, by Application, 2023 (%)
Cancer
Traumatic Brain Injury
Ebola Infection
Fertility Treatment
Others
Global Anti-Cathepsin B Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Anti-Cathepsin B Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Cathepsin B revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Anti-Cathepsin B revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck KGaA
Bio-Techne, BioVision Inc.
Santa Cruz Biotechnology, Inc.
MedChemExpress
BioCat GmbH
ApexBio Technology
Cayman Chemical
Selleck Chemicals
BOC Sciences
AG Scientific
Virobay Inc.
Abcam Plc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Cathepsin B, market overview.
Chapter 2: Global Anti-Cathepsin B market size in revenue.
Chapter 3: Detailed analysis of Anti-Cathepsin B company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Cathepsin B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-Cathepsin B Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-Cathepsin B Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Cathepsin B Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Cathepsin B Overall Market Size
2.1 Global Anti-Cathepsin B Market Size: 2023 VS 2030
2.2 Global Anti-Cathepsin B Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Cathepsin B Players in Global Market
3.2 Top Global Anti-Cathepsin B Companies Ranked by Revenue
3.3 Global Anti-Cathepsin B Revenue by Companies
3.4 Top 3 and Top 5 Anti-Cathepsin B Companies in Global Market, by Revenue in 2023
3.5 Global Companies Anti-Cathepsin B Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Cathepsin B Players in Global Market
3.6.1 List of Global Tier 1 Anti-Cathepsin B Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Cathepsin B Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-Cathepsin B Market Size Markets, 2023 & 2030
4.1.2 Primary Antibodies
4.1.3 Proteins and Peptides
4.1.4 Lysates
4.2 By Type - Global Anti-Cathepsin B Revenue & Forecasts
4.2.1 By Type - Global Anti-Cathepsin B Revenue, 2019-2024
4.2.2 By Type - Global Anti-Cathepsin B Revenue, 2025-2030
4.2.3 By Type - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-Cathepsin B Market Size, 2023 & 2030
5.1.2 Cancer
5.1.3 Traumatic Brain Injury
5.1.4 Ebola Infection
5.1.5 Fertility Treatment
5.1.6 Others
5.2 By Application - Global Anti-Cathepsin B Revenue & Forecasts
5.2.1 By Application - Global Anti-Cathepsin B Revenue, 2019-2024
5.2.2 By Application - Global Anti-Cathepsin B Revenue, 2025-2030
5.2.3 By Application - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Anti-Cathepsin B Market Size, 2023 & 2030
6.2 By Region - Global Anti-Cathepsin B Revenue & Forecasts
6.2.1 By Region - Global Anti-Cathepsin B Revenue, 2019-2024
6.2.2 By Region - Global Anti-Cathepsin B Revenue, 2025-2030
6.2.3 By Region - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Anti-Cathepsin B Revenue, 2019-2030
6.3.2 US Anti-Cathepsin B Market Size, 2019-2030
6.3.3 Canada Anti-Cathepsin B Market Size, 2019-2030
6.3.4 Mexico Anti-Cathepsin B Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Anti-Cathepsin B Revenue, 2019-2030
6.4.2 Germany Anti-Cathepsin B Market Size, 2019-2030
6.4.3 France Anti-Cathepsin B Market Size, 2019-2030
6.4.4 U.K. Anti-Cathepsin B Market Size, 2019-2030
6.4.5 Italy Anti-Cathepsin B Market Size, 2019-2030
6.4.6 Russia Anti-Cathepsin B Market Size, 2019-2030
6.4.7 Nordic Countries Anti-Cathepsin B Market Size, 2019-2030
6.4.8 Benelux Anti-Cathepsin B Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Anti-Cathepsin B Revenue, 2019-2030
6.5.2 China Anti-Cathepsin B Market Size, 2019-2030
6.5.3 Japan Anti-Cathepsin B Market Size, 2019-2030
6.5.4 South Korea Anti-Cathepsin B Market Size, 2019-2030
6.5.5 Southeast Asia Anti-Cathepsin B Market Size, 2019-2030
6.5.6 India Anti-Cathepsin B Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Anti-Cathepsin B Revenue, 2019-2030
6.6.2 Brazil Anti-Cathepsin B Market Size, 2019-2030
6.6.3 Argentina Anti-Cathepsin B Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-Cathepsin B Revenue, 2019-2030
6.7.2 Turkey Anti-Cathepsin B Market Size, 2019-2030
6.7.3 Israel Anti-Cathepsin B Market Size, 2019-2030
6.7.4 Saudi Arabia Anti-Cathepsin B Market Size, 2019-2030
6.7.5 UAE Anti-Cathepsin B Market Size, 2019-2030
7 Anti-Cathepsin B Companies Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Company Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Anti-Cathepsin B Major Product Offerings
7.1.4 Merck KGaA Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.1.5 Merck KGaA Key News & Latest Developments
7.2 Bio-Techne, BioVision Inc.
7.2.1 Bio-Techne, BioVision Inc. Company Summary
7.2.2 Bio-Techne, BioVision Inc. Business Overview
7.2.3 Bio-Techne, BioVision Inc. Anti-Cathepsin B Major Product Offerings
7.2.4 Bio-Techne, BioVision Inc. Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.2.5 Bio-Techne, BioVision Inc. Key News & Latest Developments
7.3 Santa Cruz Biotechnology, Inc.
7.3.1 Santa Cruz Biotechnology, Inc. Company Summary
7.3.2 Santa Cruz Biotechnology, Inc. Business Overview
7.3.3 Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Major Product Offerings
7.3.4 Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.3.5 Santa Cruz Biotechnology, Inc. Key News & Latest Developments
7.4 MedChemExpress
7.4.1 MedChemExpress Company Summary
7.4.2 MedChemExpress Business Overview
7.4.3 MedChemExpress Anti-Cathepsin B Major Product Offerings
7.4.4 MedChemExpress Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.4.5 MedChemExpress Key News & Latest Developments
7.5 BioCat GmbH
7.5.1 BioCat GmbH Company Summary
7.5.2 BioCat GmbH Business Overview
7.5.3 BioCat GmbH Anti-Cathepsin B Major Product Offerings
7.5.4 BioCat GmbH Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.5.5 BioCat GmbH Key News & Latest Developments
7.6 ApexBio Technology
7.6.1 ApexBio Technology Company Summary
7.6.2 ApexBio Technology Business Overview
7.6.3 ApexBio Technology Anti-Cathepsin B Major Product Offerings
7.6.4 ApexBio Technology Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.6.5 ApexBio Technology Key News & Latest Developments
7.7 Cayman Chemical
7.7.1 Cayman Chemical Company Summary
7.7.2 Cayman Chemical Business Overview
7.7.3 Cayman Chemical Anti-Cathepsin B Major Product Offerings
7.7.4 Cayman Chemical Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.7.5 Cayman Chemical Key News & Latest Developments
7.8 Selleck Chemicals
7.8.1 Selleck Chemicals Company Summary
7.8.2 Selleck Chemicals Business Overview
7.8.3 Selleck Chemicals Anti-Cathepsin B Major Product Offerings
7.8.4 Selleck Chemicals Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.8.5 Selleck Chemicals Key News & Latest Developments
7.9 BOC Sciences
7.9.1 BOC Sciences Company Summary
7.9.2 BOC Sciences Business Overview
7.9.3 BOC Sciences Anti-Cathepsin B Major Product Offerings
7.9.4 BOC Sciences Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.9.5 BOC Sciences Key News & Latest Developments
7.10 AG Scientific
7.10.1 AG Scientific Company Summary
7.10.2 AG Scientific Business Overview
7.10.3 AG Scientific Anti-Cathepsin B Major Product Offerings
7.10.4 AG Scientific Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.10.5 AG Scientific Key News & Latest Developments
7.11 Virobay Inc.
7.11.1 Virobay Inc. Company Summary
7.11.2 Virobay Inc. Business Overview
7.11.3 Virobay Inc. Anti-Cathepsin B Major Product Offerings
7.11.4 Virobay Inc. Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.11.5 Virobay Inc. Key News & Latest Developments
7.12 Abcam Plc
7.12.1 Abcam Plc Company Summary
7.12.2 Abcam Plc Business Overview
7.12.3 Abcam Plc Anti-Cathepsin B Major Product Offerings
7.12.4 Abcam Plc Anti-Cathepsin B Revenue in Global Market (2019-2024)
7.12.5 Abcam Plc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-Cathepsin B Market Opportunities & Trends in Global Market
Table 2. Anti-Cathepsin B Market Drivers in Global Market
Table 3. Anti-Cathepsin B Market Restraints in Global Market
Table 4. Key Players of Anti-Cathepsin B in Global Market
Table 5. Top Anti-Cathepsin B Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Anti-Cathepsin B Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Anti-Cathepsin B Revenue Share by Companies, 2019-2024
Table 8. Global Companies Anti-Cathepsin B Product Type
Table 9. List of Global Tier 1 Anti-Cathepsin B Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Cathepsin B Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Anti-Cathepsin B Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Anti-Cathepsin B Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Anti-Cathepsin B Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Anti-Cathepsin B Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Anti-Cathepsin B Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Anti-Cathepsin B Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Anti-Cathepsin B Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Anti-Cathepsin B Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Anti-Cathepsin B Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Anti-Cathepsin B Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Anti-Cathepsin B Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Anti-Cathepsin B Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Anti-Cathepsin B Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Anti-Cathepsin B Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Anti-Cathepsin B Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Anti-Cathepsin B Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Anti-Cathepsin B Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Anti-Cathepsin B Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Anti-Cathepsin B Revenue, (US$, Mn), 2025-2030
Table 30. Merck KGaA Company Summary
Table 31. Merck KGaA Anti-Cathepsin B Product Offerings
Table 32. Merck KGaA Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 33. Merck KGaA Key News & Latest Developments
Table 34. Bio-Techne, BioVision Inc. Company Summary
Table 35. Bio-Techne, BioVision Inc. Anti-Cathepsin B Product Offerings
Table 36. Bio-Techne, BioVision Inc. Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 37. Bio-Techne, BioVision Inc. Key News & Latest Developments
Table 38. Santa Cruz Biotechnology, Inc. Company Summary
Table 39. Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Product Offerings
Table 40. Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 41. Santa Cruz Biotechnology, Inc. Key News & Latest Developments
Table 42. MedChemExpress Company Summary
Table 43. MedChemExpress Anti-Cathepsin B Product Offerings
Table 44. MedChemExpress Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 45. MedChemExpress Key News & Latest Developments
Table 46. BioCat GmbH Company Summary
Table 47. BioCat GmbH Anti-Cathepsin B Product Offerings
Table 48. BioCat GmbH Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 49. BioCat GmbH Key News & Latest Developments
Table 50. ApexBio Technology Company Summary
Table 51. ApexBio Technology Anti-Cathepsin B Product Offerings
Table 52. ApexBio Technology Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 53. ApexBio Technology Key News & Latest Developments
Table 54. Cayman Chemical Company Summary
Table 55. Cayman Chemical Anti-Cathepsin B Product Offerings
Table 56. Cayman Chemical Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 57. Cayman Chemical Key News & Latest Developments
Table 58. Selleck Chemicals Company Summary
Table 59. Selleck Chemicals Anti-Cathepsin B Product Offerings
Table 60. Selleck Chemicals Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 61. Selleck Chemicals Key News & Latest Developments
Table 62. BOC Sciences Company Summary
Table 63. BOC Sciences Anti-Cathepsin B Product Offerings
Table 64. BOC Sciences Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 65. BOC Sciences Key News & Latest Developments
Table 66. AG Scientific Company Summary
Table 67. AG Scientific Anti-Cathepsin B Product Offerings
Table 68. AG Scientific Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 69. AG Scientific Key News & Latest Developments
Table 70. Virobay Inc. Company Summary
Table 71. Virobay Inc. Anti-Cathepsin B Product Offerings
Table 72. Virobay Inc. Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 73. Virobay Inc. Key News & Latest Developments
Table 74. Abcam Plc Company Summary
Table 75. Abcam Plc Anti-Cathepsin B Product Offerings
Table 76. Abcam Plc Anti-Cathepsin B Revenue (US$, Mn) & (2019-2024)
Table 77. Abcam Plc Key News & Latest Developments
List of Figures
Figure 1. Anti-Cathepsin B Segment by Type in 2023
Figure 2. Anti-Cathepsin B Segment by Application in 2023
Figure 3. Global Anti-Cathepsin B Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Anti-Cathepsin B Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Anti-Cathepsin B Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Cathepsin B Revenue in 2023
Figure 8. By Type - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 9. By Application - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 10. By Type - Global Anti-Cathepsin B Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 12. By Application - Global Anti-Cathepsin B Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 14. By Region - Global Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 15. By Country - North America Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 16. US Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 20. Germany Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 21. France Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 28. China Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 32. India Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 34. Brazil Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Anti-Cathepsin B Revenue Market Share, 2019-2030
Figure 37. Turkey Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Anti-Cathepsin B Revenue, (US$, Mn), 2019-2030
Figure 41. Merck KGaA Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Bio-Techne, BioVision Inc. Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Santa Cruz Biotechnology, Inc. Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. MedChemExpress Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. BioCat GmbH Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. ApexBio Technology Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Cayman Chemical Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Selleck Chemicals Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. BOC Sciences Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. AG Scientific Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Virobay Inc. Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Abcam Plc Anti-Cathepsin B Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
